Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
22,107,985
-
Total 13F shares
-
11,489,024
-
Share change
-
+15,173
-
Total reported value
-
$52,045,719
-
Put/Call ratio
-
129%
-
Price per share
-
$4.53
-
Number of holders
-
47
-
Value change
-
+$676,163
-
Number of buys
-
12
-
Number of sells
-
36
Institutional Holders of Adverum Biotechnologies, Inc. - Common Stock, $0.0001 par value per share (ADVM) as of Q3 2025
As of 30 Sep 2025 Adverum Biotechnologies, Inc. - Common Stock, $0.0001 par value per share (ADVM) had 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 11,489,024 shares of stock of the company.
Largest 10 holders included BML Capital Management, LLC, Frazier Life Sciences Management, L.P., TCG Crossover Management, LLC, VANGUARD GROUP INC, 5AM Venture Management, LLC, GOLDMAN SACHS GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Pale Fire Capital SE, MILLENNIUM MANAGEMENT LLC, and BlackRock, Inc..
This table shows 47 institutional shareholders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.